Market Overview

  • Citicoline’s market size was USD 0.43 billion in 2023 and is anticipated to increase from USD 0.48 billion in 2024 to USD 1.04 billion by 2032, with a compound annual growth rate (CAGR) of 8.99% during the forecast period (2024-2032).
  • The report underscores that the primary factors driving the market’s expansion are the increasing prevalence of neurological disorders, the growing geriatric population, and the increasing demand for cognitive enhancement. In recent years, there has been a significant change in public perception toward the significance of preserving brain health and cognitive function throughout one’s existence. This change can be attributed to a variety of factors, such as an increasing aging population, increased concerns about cognitive decline, and neurodegenerative diseases like Alzheimer’s. Additionally, there is greater access to information today.


Market segment insights

  • The Citicoline Market segmentation is categorized by type and includes capsules, tablets, powder, ocular drops, and injections.
  • Market segmentation is determined by applications, which encompass treatment, personal wellness, and sports nutrition. Additionally, treatment is further divided into categories such as glaucoma, stroke, Alzheimer’s disease, bipolar depression, and others.
  • The Citicoline Market segmentation is based on age category, which includes Pediatric, adult, and geriatric.
  • The market segmentation is determined by the distribution channel, which encompasses both online and offline channels.


Regional Perspectives

  • In 2022, the North American citicoline market held the highest market share. The reason for this is the expanding geriatric population, high per capita disposable income, and increasing number of facial correction and improvement procedures in the North American region.
  • The second-largest market share in the Europe citicoline market is attributed to the region’s robust pharmaceutical and healthcare infrastructure, as well as the geriatric population. In addition, the German citicoline market was identified as having the highest market share, while the Spanish citicoline market is anticipated to experience the quickest growth in the European region.
  • It is anticipated that the Asia-Pacific citicoline market will experience substantial growth from 2024 to 2032. This is a result of the growing recognition of the potential benefits of citicoline supplementation and cognitive health in the Asia-Pacific region. In addition, the China citicoline market is anticipated to have the highest market share, while the India citicoline market is anticipated to be the fastest-growing market in the Asia-Pacific region.
  • The Middle East, Africa, and Latin America comprise the Rest of the World. The Citicoline Market in the regions is expected to experience growth as a result of the increasing awareness of cognitive health and the growth of the elderly population.


Major Players
Kyowa Hakko Bio Co., Ltd (Japan), Vitabiotics Ltd (UK), Grupo Ferrer Internacional, S.A (Spain), UNION KOREA PHARM CO LTD (South Korea), Invision Medi Sciences (India), RPG Life Sciences Ltd (India), CHEMO BIOLOGICAL (India), Century Pharma (India), HARBIN PHARMACEUTICAL GROUP (China), and Life Extension (US) are among the companies in this category.